Harbour Trust & Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Harbour Trust & Investment Management's ABBV Position: Q2 2026 in Review
Harbour Trust & Investment Management reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $39.6K and leaving 14,893 shares worth $3.75M. The position accounts for 0.36% of the portfolio, ranked #57.
Harbour Trust & Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,116 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Harbour Trust & Investment Management held 14,893 shares of AbbVie worth $3.75M as of Q2 2026.
- Harbour Trust & Investment Management sold 184 AbbVie shares in Q2 2026, an estimated $39.6K.
- AbbVie made up 0.36% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #57 holding.
- Harbour Trust & Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- 2,116 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.